Sally Ward

Sally Ward

Company: University of Southampton

Job title: Director of Translational Immunology & Professor of Molecular Immunology


Targeting FcRn to Generate Antibody-Based Therapeutics: From Discovery to Pre-clinical Translation 9:30 am

Identification of FcRn as the global regulator of IgG levels, leading to FcRn antagonist technology. Targeting FcRn to selectively deplete antigen-specific antibodies.Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.